0001209191-20-020756.txt : 20200323
0001209191-20-020756.hdr.sgml : 20200323
20200323193335
ACCESSION NUMBER: 0001209191-20-020756
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200319
FILED AS OF DATE: 20200323
DATE AS OF CHANGE: 20200323
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abdollahian Neil
CENTRAL INDEX KEY: 0001678223
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 20736260
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cidara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001610618
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461537286
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-752-6170
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: K2 THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140611
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-19
0
0001610618
Cidara Therapeutics, Inc.
CDTX
0001678223
Abdollahian Neil
6310 NANCY RIDGE DR
SUITE 101
SAN DIEGO
CA
92121
0
1
0
0
Chief Business Officer
Employee Stock Option (right to buy)
1.98
2020-03-19
4
A
0
115000
0.00
A
2030-03-18
Common Stock
115000
115000
D
The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 19, 2020.
/s/ Jessica Oien, Attorney-in-fact
2020-03-23